Identification of reciprocally regulated gene modules in regenerating dorsal root ganglion neurons and activated peripheral or central nervous system glia.
Differential gene expression in the rat after injury of dorsal root ganglion neurons in vivo, and simulation injury of Schwann cells and oligodendrocytes in vitro was analyzed using high-density cDNA microarrays. The analyses were carried out to study the genetic basis of peripheral nerve regeneration, and to compare gene regulation in glia of the central (oligodendrocyte) and peripheral (Schwann cell) nervous systems. The genes showing significant differential regulation in the three study groups represented all aspects of cellular metabolism. However, two unexpected observations were made. Firstly, a number of identical genes were differentially regulated in activated Schwann cells, activated oligodendrocytes and regenerating DRG neurons. Specifically, a group of 113 out of 210 genes that were down-regulated in Schwann cells upon lipopolysaccharide (LPS) treatment, were identical to genes up-regulated in the injured, regenerating DRG. Furthermore, a group of 53 out of 71 genes that were down-regulated in interferon gamma (IFN-gamma)/LPS-activated oligodendrocytes, were identical to genes up-regulated in the DRG neurons. Finally, 22 genes were common to these three groups, i.e., down-regulated in activated oligodendrocytes, down-regulated in activated Schwann cells, and up-regulated in regenerating DRG neurons. Secondly, a group of 16 cell-cycle and proliferation-related genes were up-regulated in the DRG following sciatic nerve crush, despite the absence of cells undergoing mitosis in the DRG, or any significant presence of apoptosis-related gene expression. Therefore, it appears that in these three cell types, large sets of genes are reciprocally regulated upon injury and/or activation. This suggests that the activation of the injury-related gene expression program in cell derivatives of the neuroectoderm involves, in part, highly conserved genetic elements.
Cameron
Adrian A
AA
The Immune Response Corporation, 5935 Darwin Court, Carlsbad, California 92008, USA.
Vansant
Gordon
G
Wu
Wen
W
Carlo
Dennis J
DJ
Ill
Charles R
CR
D000818:Animals; D002478:Cells, Cultured; D002490:Central Nervous System / Q000293:injuries / Q000502:physiology*; D005260:Female; D005727:Ganglia, Spinal / Q000293:injuries / Q000502:physiology*; D005786:Gene Expression Regulation / Q000235:genetics*; D007371:Interferon-gamma; D008070:Lipopolysaccharides; D005810:Multigene Family; D009416:Nerve Regeneration / Q000235:genetics*; D009457:Neuroglia / Q000187:drug effects / Q000378:metabolism / Q000502:physiology; D009474:Neurons / Q000187:drug effects / Q000502:physiology; D009836:Oligodendroglia / Q000187:drug effects / Q000502:physiology; D020411:Oligonucleotide Array Sequence Analysis; D017933:Peripheral Nervous System / Q000293:injuries / Q000502:physiology*; D016133:Polymerase Chain Reaction; D012333:RNA, Messenger / Q000032:analysis / Q000302:isolation & purification; D051381:Rats; D017207:Rats, Sprague-Dawley; D012583:Schwann Cells / Q000187:drug effects / Q000502:physiology; D014158:Transcription, Genetic / Q000235:genetics*
D008070:Lipopolysaccharides; D012333:RNA, Messenger; D007371:Interferon-gamma